...
首页> 外文期刊>BMC Veterinary Research >Efficacy of live attenuated porcine reproductive and respiratory syndrome virus 2 strains to protect pigs from challenge with a heterologous Vietnamese PRRSV 2 field strain
【24h】

Efficacy of live attenuated porcine reproductive and respiratory syndrome virus 2 strains to protect pigs from challenge with a heterologous Vietnamese PRRSV 2 field strain

机译:减毒活猪繁殖与呼吸综合征病毒2株保护猪免受异源越南PRRSV 2田间毒株攻击的功效

获取原文
           

摘要

Effective vaccines against porcine reproductive and respiratory syndrome virus (PRRSV), especially against highly pathogenic (HP) PRRSV are still missing. The objective of this study was to evaluate the protective efficacy of an experimental live attenuated PRRSV 2 vaccine, composed of two strains, against heterologous challenge with a Vietnamese HP PRRSV 2 field strain. For this reason, 20 PRRSV negative piglets were divided into two groups. The pigs of group 1 were vaccinated with the experimental vaccine, group 2 remained unvaccinated. All study piglets received an intranasal challenge of the HP PRRSV 2 on day 0 of the study (42?days after vaccination). Blood samples were taken on days 7 and 21 after vaccination and on several days after challenge. On day 28 after challenge, all piglets were euthanized and pathologically examined. On days 7 and 21 after vaccination, a PRRSV 2 viraemia was seen in all piglets of group 1 which remained detectable in seven piglets up to 42?days after vaccination. On day 3 after challenge, all piglets from both groups were positive in PRRSV 2 RT-qPCR. From day 7 onwards, viral load and number of PRRSV 2 positive pigs were lower in group 1 than in group 2. All pigs of group 1 seroconverted after PRRSV 2 vaccination. PRRSV antibodies were detected in serum of all study pigs from both groups from day 14 after challenge onwards. In group 2, moderate respiratory symptoms with occasional coughing were seen following the challenge with HP PRRSV 2. Pigs of group 1 remained clinically unaffected. Interstitial pneumonia was found in four piglets of group 1 and in all ten piglets of group 2. Histopathological findings were more severe in group 2. It was thus concluded that the used PRRSV 2 live experimental vaccine provided protection from clinical disease and marked reduction of histopathological findings and viral load in pigs challenged with a Vietnamese HP PRRSV 2 field strain.
机译:仍然缺少针对猪繁殖与呼吸综合症病毒(PRRSV),特别是针对高致病性(HP)PRRSV的有效疫苗。这项研究的目的是评估由两种菌株组成的实验性减毒活PRRSV 2疫苗对越南HP PRRSV 2野外菌株的异源攻击的保护作用。因此,将20头PRRSV阴性仔猪分为两组。第一组的猪接种了实验疫苗,第二组的猪仍未接种疫苗。所有研究仔猪在研究的第0天(接种疫苗后42天)都接受了鼻内HP PRRSV 2的攻击。疫苗接种后第7天和第21天以及激发后几天采集血样。攻击后第28天,对所有仔猪实施安乐死并进行病理检查。在接种后第7天和第21天,在第1组的所有仔猪中均观察到PRRSV 2病毒血症,在接种后直至42天的7头仔猪中仍可检出。攻击后第3天,两组的所有仔猪PRRSV 2 RT-qPCR均为阳性。从第7天起,第1组的病毒载量和PRRSV 2阳性猪的数量均低于第2组。第1组的所有猪在接种PRRSV 2后均发生血清转化。从攻击开始第14天起,在两组所有研究猪的血清中检测到PRRSV抗体。在第2组中,HP PRRSV 2攻击后出现中度呼吸道症状,偶尔出现咳嗽。第1组的猪在临床上未受影响。在第1组的4头仔猪和第2组的所有10头仔猪中发现间质性肺炎。在第2组中,组织病理学发现更为严重。因此得出结论,使用的PRRSV 2活体实验疫苗可提供针对临床疾病的保护作用,并显着减少组织病理越南HP PRRSV 2田间病毒株感染猪的研究结果和病毒载量。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号